Wound Healing Complications and Infection Following Surgery for Rheumatoid Arthritis

Foot and Ankle Clinics

Volumn 12, Issue 3, 2007, Pages 509-524

  Bibbo, Christopher ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT;

BACTERIAL INFECTION; HUMAN; METHODOLOGY; ORTHOPEDIC SURGERY; PATHOPHYSIOLOGY; PEROPERATIVE CARE; POSTOPERATIVE COMPLICATION; REVIEW; RHEUMATOID ARTHRITIS; VEIN THROMBOSIS; WOUND HEALING;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BACTERIAL INFECTIONS; HUMANS; INTRAOPERATIVE CARE; ORTHOPEDIC PROCEDURES; POSTOPERATIVE COMPLICATIONS; VENOUS THROMBOSIS; WOUND HEALING;

EID: 34548207270     PISSN: 10837515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fcl.2007.04.005     Document Type: Review

References (36)

1. Engeland C.G., Bosch J.A., Cacioppo J.T., et al. Mucosal wound healing: the roles of age and sex. Arch Surg 141 12 (2006) 1193-1197
2. Lenhardt R., Hopf H.W., Marker E., et al. Perioperative collagen deposition in elderly and young men and women. Arch Surg 135 1 (2000) 71-74
3. Agah A., Kyriakides T.R., Letrondo N., et al. Thrombospondin 2 levels are increased in aged mice: consequences for cutaneous wound healing and angiogenesis. Matrix Biol 22 7 (2004) 539-547
4. Roh C., and Lyle S. Cutaneous stem cells and wound healing. Pediatr Res 59 4 Pt 2 (2006) 100R-103R
5. Bibbo C. The assessment and perioperative management of patients with rheumatoid arthritis. Techniques in Foot & Ankle Surgery 3 (2004) 126-135
6. Gorman J.D., Sack K.E., and Davis Jr. J.C. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med 346 (2002) 1349-1356
7. Moreland L.W., Bucy R.P., Weinblatt M.E., et al. Immune function in patients with rheumatoid arthritis treated with etanercept. Clin Immunol 103 (2002) 13-21
8. Weinblatt M.E., Kremer J.M., Bankhurst A.D., et al. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340 (1999) 253-259
9. Yazici Y., Erkan D., and Lockshin M.D. A preliminary study of etanercept in the treatment of severe resistant psoriatic arthritis. Clin Exp Rheumatol 18 (2000) 732-734
10. Bibbo C., and Goldberg J.W. Infectious and healing complications after elective orthopaedic foot and ankle surgery during tumor necrosis factor-alpha inhibition therapy. Foot Ankle Int 25 5 (2004) 331-335
11. Alldred A. Etanercept in rheumatoid arthritis. Expert Opin Pharmacother 7 (2001) 1137-1148
12. Capsoni F., Sarzi-Puttini P., Atzeni F., et al. Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis. Arthritis Res Ther 7 (2005) R250-R255
13. Catrina A.I., Trollmo C., af Klint E., et al. Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report. Arthritis Rheum 52 1 (2005) 61-72
14. Catrina A.I., af Klint E., Ernestam S., et al. Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis. Arthritis Rheum 54 1 (2006) 76-81
15. Rapala K. The effect of tumor necrosis factor-alpha on wound healing. An experimental study. Ann Chir Gynaecol Suppl 211 (1996) 1-53
16. Rapala K., Laato M., Niinikoski J., et al. Tumor necrosis factor alpha inhibits wound healing in the rat. Eur Surg Res 23 5-6 (1991) 261-268
17. Rapala K.T., Vaha-Kreula M.O., Heino J.J., et al. Tumor necrosis factor-alpha inhibits collagen synthesis in human and rat granulation tissue fibroblasts. Experientia 52 1 (1996) 70-74
18. Lee R.H., Efron D.T., Tantry U., et al. Inhibition of tumor necrosis factor-alpha attenuates wound breaking strength in rats. Wound Repair Regen 8 6 (2000) 547-553
19. Rapala K., Peltonen J., Heino J., et al. Tumour necrosis factor-alpha selectivity modulates expression of collagen genes in rat granulation tissue. Eur J Surg 163 3 (1997) 207-214
20. Maish III G.O., Shumate M.L., Ehrlich H.P., et al. Interleukin-1 receptor antagonist attenuates tumor necrosis factor-induced alterations in wound breaking strength. J Trauma 47 3 (1999) 533-537
21. Regan M.C., Kirk S.J., Hurson M., et al. Tumor necrosis factor-alpha inhibits in vivo collagen synthesis. Surgery 113 2 (1993) 173-177
22. Bongartz T., Sutton A.J., Sweeting M.J., et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295 19 (2006) 2275-2285
23. Listing J., Strangfeld A., Kary S., et al. Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum 52 11 (2005) 3403-3412
24. Dixon W.G., Watson K., Lunt M., et al. British Society for Rheumatology Biologics Register. Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 54 8 (2006) 2368-2376
25. Grennan D.M., Gray J., Loudon J., et al. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis 60 3 (2001) 214-217
26. Perhala R.S., Wilke W.S., Clough J.D., et al. Local infectious complications following large joint replacement in rheumatoid arthritis patients treated with methotrexate versus those not treated with methotrexate. Arthritis Rheum 34 (1991) 146-152
27. Escalante A., and Beardmore T.D. Risk factors for early wound complications after orthopedic surgery for rheumatoid arthritis. J Rheumatol 22 (1995) 1844-1851
28. Tanaka N., Sakahashi H., Sato E., et al. Examination of the risk of continuous leflunomide treatment on the incidence of infectious complications after joint arthroplasty in patients with rheumatoid arthritis. J Clin Rheumatol 9 (2003) 115-118
29. Fuerst M., Mohl H., Baumgartel K., et al. Leflunomide increases the risk of early healing complications in patients with rheumatoid arthritis undergoing elective orthopedic surgery. Rheumatol Int 26 (2006) 1138-1142
30. Bibbo C., Anderson R.B., Davis W.H., et al. The influence of rheumatoid chemotherapy, age, and presence of rheumatoid nodules on postoperative complications in rheumatoid foot and ankle surgery: analysis of 725 procedures in 104 patients. Foot Ankle Int 24 1 (2003) 40-44
31. Reize P., Ina Leichtle C., Leichtle U.G., et al. Long-term results after metatarsal head resection in the treatment of rheumatoid arthritis. Foot Ankle Int 27 (2006) 586-590
32. Anderson T., Linder L., Rydholm U., et al. Tibio-talocalcaneal arthrodesis as a primary procedure using a retrograde intramedullary nail: a retrospective study of 26 patients with rheumatoid arthritis. Acta Orthop 76 (2005) 580-587
33. Anderson T., Maxander P., Rydholm U., et al. Ankle arthrodesis by compression screws in rheumatoid arthritis: primary union in 9/35 patients. Acta Orthop 76 (2005) 884-890
34. Nagashima M., Tachihara A., Matsuzaki T., et al. Follow-up of ankle arthrodesis in severe hind foot deformity in patients with rheumatoid arthritis using an intramedullary nail with fins. Mod Rheumatol 15 (2005) 269-274
35. Bassettei S., Wasmer S., Hasler P., et al. Staphylococcus aureus in patients with rheumatoid arthritis under conventional and anti-tumor necrosis factor-alpha treatment. J Rheumatol 32 (2005) 2125-2129
36. Barbari E.F., Osmon D.R., Duffy M.C., et al. Outcome of prosthetic joint infection in patients with rheumatoid arthritis: the impact of medical and surgical therapy in 200 patients. Clin Infect Dis 42 (2006) 216-223